Ahs Cancer Control Alberta
Clinical trials sponsored by Ahs Cancer Control Alberta, explained in plain language.
-
Could a simple asthma drug prevent a dangerous immunotherapy side effect?
Disease control Recruiting nowThis study tests whether a year of inhaled budesonide (a common asthma medication) can prevent lung inflammation from coming back in cancer patients who had a serious immune reaction to immunotherapy. About 94 adults with solid tumors who recently recovered from checkpoint inhibi…
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated May 26, 2026 08:56 UTC
-
Could skipping groin radiation improve life for anal cancer patients?
Disease control Recruiting nowThis study looks at whether it is safe to skip preventive radiation to the groin in people with early-stage anal cancer who have no signs of cancer in their groin lymph nodes. About 45 participants will receive standard treatment but without groin radiation. Researchers want to s…
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Could less steroids be better for Immunotherapy-Related liver issues?
Disease control Recruiting nowThis study looks at whether closely watching and only using steroids when needed is as safe and effective as giving high-dose steroids right away for liver inflammation caused by cancer immunotherapy. About 56 adults with grade 2 or 3 liver inflammation will be randomly assigned …
Phase: NA • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New hope for elderly brain cancer patients: shorter, gentler treatment tested
Disease control Recruiting nowThis study tests whether chemotherapy alone works as well as the standard combination of chemotherapy and radiation for elderly or frail patients with a type of brain cancer called glioblastoma. About 107 participants aged 65 and older with limited physical function will be rando…
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
Allergy pill may ease bone pain for stem cell donors
Symptom relief Recruiting nowThis study tests whether loratadine, a common allergy medicine, can prevent or reduce bone pain caused by G-CSF injections used to collect stem cells. About 78 adults with lymphoma or multiple myeloma undergoing stem cell transplant will receive either loratadine or a placebo. Th…
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Symptom relief
Last updated May 26, 2026 08:58 UTC
-
Home chemo: a new way to treat myeloma?
Symptom relief Recruiting nowThis study looks at whether people with multiple myeloma can safely give themselves a standard chemotherapy injection (bortezomib) at home, instead of always going to the hospital. About 100 adults who are stable on treatment and have already had several injections in the clinic …
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Symptom relief
Last updated May 26, 2026 08:33 UTC
-
New combo therapy aims to help advanced esophageal cancer patients swallow easier
Symptom relief Recruiting nowThis study is for people with advanced esophageal cancer that cannot be cured. It tests whether adding two chemotherapy drugs (carboplatin and paclitaxel) to standard radiation therapy can better relieve trouble swallowing and improve quality of life. About 50 adults with swallow…
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Symptom relief
Last updated May 22, 2026 13:50 UTC